TipRanks on MSN
PepGen Inc. Advances DM1 Treatment with New Clinical Study
PepGen Inc. (($PEPG)) announced an update on their ongoing clinical study. PepGen Inc. has announced a new clinical study titled ‘An Open-Label ...
Mistry described Scp776 as a “designer drug.” She explained that IGF-1 receptors are abundant throughout the body, and IGF-1 ...
TipRanks on MSN
NRx Pharmaceuticals (NRXP) Advancing Two-Pronged Approach to Bring Innovative Therapies to Market
NRx Pharmaceuticals (NASDAQ: NRXP) was featured in a recent article that discussed its approach to bring preservative-free ...
A swanky $16m private wellness club offering the chance of a longer life and slowing the ageing process — and where ...
Phase 3b LUCENT-URGE is the first study in inflammatory bowel disease to assess bowel urgency across three measures — severity, frequency and stool deferral time — reflecting the spectrum of its ...
BeOne Medicines (($ONC)) announced an update on their ongoing clinical study. Study Overview: BeOne Medicines (ONC) is conducting a Phase 1 ...
A new study published in Music and Medicine reveals that intraoperative music therapy significantly reduces the amount of propofol required during laparoscopic cholecystectomy performed ...
Studies show patients with chronic kidney disease (CKD) and COVID-19 are at increased risk for an intensive care unit stay and early death. Anemia is an extra risk factor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback